Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 12, 2023
Eurofins CDMO Alphora Inc. announced the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.
read more
Eurofins CDMO Alphora Inc. announced the expansion of its API capacity and capabilities with the completion of its new API manufacturing facility at its site in Mississauga, Canada.
read more
Thursday, January 18, 2024
Eurofins CDMO Alphora Inc., a Contract Drug and Manufacturing Organization based in Mississauga, Canada, announced the successful completion of its pilot-scale biologics development facility.
read more
Eurofins CDMO Alphora Inc. announced a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold. Located in Mississauga, Canada, the expanded facility marks the addition of specialized equipment ...
read more
Thursday, October 05, 2023
Eurofins CDMO Alphora Inc. announced the launch of its Biologics initiative, as part of its vision to diversify and grow within the contract development and manufacturing industry in North America.
read more
Thursday, January 13, 2022
Eurofins CDMO announces the expansion of existing Spray Dry Development & Production Services in North America.
read more
Eurofins Discovery announced the acquisition of DiscoveryBioMed, a contract research organization (CRO) focused on developing novel human bioassays utilizing cells from diseased and normal human tissues.
read more
Eurofins Discovery and ImmunoPrecise Antibodies, the announced a commercial collaboration. Leveraging complementary strengths in Eurofins Discovery's in vitro pharmacology services and ImmunoPrecise's in vivo characterization and discovery ...
read more
Wednesday, April 10, 2019
Eurofins Discovery announced its premier offering for integrated drug discovery services.
read more
Eurofins Discovery announced the formation of its new Scientific Advisory Board (SAB). Company officials gathered renowned leaders from the pharmaceutical and biotechnology industries to gain strategic insights to address the unmet needs in drug ...
read more
Eurofins Discovery announces the launch of new services in support of clients working to address the immune consequences of SARS-CoV-2 and other infectious disease.
read more
Friday, December 10, 2021
Eurofins Scientific a global provider of bioanalytical testing and clinical diagnostics testing, announced a share purchase agreement with Transgenic Inc. to acquire Genetic Lab Co, Ltd, a molecular biology-based testing provider for diagnostics, ...
read more
Eurofins Scientific has announced its entry into the biopharmaceutical products testing market in the Asia Pacific region with the acquisition of ams Laboratories Pty Ltd. (“ams Laboratories”), an independent analytical and cGMP Quality Control (QC) ...
read more
Thursday, September 01, 2016
Eurofins Scientific has announced the acquisition of VRL Laboratories, one of the leading laboratories in pre-transplant testing for the eligibility determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) in ...
read more
Thursday, December 03, 2015
Eurofins Scientific a provider of bioanalytical testing of food, pharmaceuticals and the environment, it has signed an agreement to acquire Biotech-Germande SAS (BG), one of the leading players in the environmental clinical testing and hospital ...
read more